Quality of life and symptom burden among hematologic malignancy patients undergoing CAR-T therapy: a cross-sectional study

Quality of life and symptom burden among hematologic malignancy patients undergoing CAR-T therapy: a cross-sectional study

Abstract Few studies have thoroughly evaluated the symptom burden and quality of life (QOL) among patients diagnosed with hematologic malignancies who underwent chimeric antigen receptor T-cell (CAR-T) therapy. In total, 97 eligible patients completed the Functional Assessment of Cancer Therapy gene...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongyuan Dai, Shuya Xu, Zengxiang Wang, Zhenyu Li, Jiang Cao, Tingyu Hu, Fang Zhou
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Chimeric receptor antigens T-cell therapy
Quality of life
Symptom burden
Hematological malignancies
Online Access:https://doi.org/10.1038/s41598-025-02720-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-02720-6

Similar Items